CureDuchenne Announces Partnership with Tevard Biosciences to Advance Suppressor tRNA Therapy for the Treatment of Duchenne Muscular Dystrophy

Tevard Biosciences to present most recent data to Duchenne community for first time at CureDuchenne FUTURES National Conference on May 22 with webinar to follow on May 28 NEWPORT BEACH, Calif., May 20, 2026 /PRNewswire/ -- CureDuchenne, a global leader in funding and advancing research...